GrabarS, Selinger-LenemanH, AbgrallS, PialouxG, WeissL, CostagliolaD. Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV. AIDS, 2009; 23:1163–1169.
2.
LambotteO, BoufassaF, MadecYet al.HIV controllers: A homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin Infect Dis, 2005; 41:1053–1056.
3.
LorelloG, la PorteC, PilonR, ZhangG, KarnauchowT, MacPhersonP. Discordance in HIV-1 viral loads and antiretroviral drug concentrations comparing semen and blood plasma. HIV Med, 2009; 10:548–554.
4.
OkuliczJF, MarconiVC, LandrumMCet al.Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defence HIV natural history study. J Infect Dis, 2009; 200:1714–1723.
5.
MadecY, BoufassaS, PorterJet al.Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters. AIDS, 2005; 19:2001–2007.
6.
HuntPW, BrenchleyJ, SinclairEet al.Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis, 2008; 197:126–133.
7.
ChiltonDN, CastroH, LattimoreSet al.HIV type-1 drug resistance in antiretroviral treatment-naïve adults infected with non-B subtype virus in the United Kingdom. Antivir Ther, 2010; 15:985–991.
8.
MetznerKJ, RauchP, WalterHet al.Detection of minor populations of drug-resistant HIV-1 in acute seroconverters. AIDS, 2005; 19:1819–1825.
9.
YerlyS, RakikA, Kinloch de LoesSet al.Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconverters infected with zidovudine-resistant variants. J Virol, 1998; 72:3520–3523.
10.
GallegoO, de MendozaC, CorralALet al.Low rates of HI-1 codon revertants in antiretroviral experienced patients. AIDS, 2003; 17:919–921.
